NCT04212832View on ClinicalTrials.gov

Quadratus Lumborum Block for Congenital Hip Dislocation Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

December 15, 2018

Study Completion Date

April 15, 2019

Conditions
Congenital Hip Dislocation
Interventions
DRUG

Bupivacaine

0.5 ml/kg %0.25 bupivacaine

OTHER

Standard pain

Standard pain follow up and monitorization

Trial Locations (1)

25100

Ataturk University, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT04212832 - Quadratus Lumborum Block for Congenital Hip Dislocation Surgery | Biotech Hunter | Biotech Hunter